Search

everythinglearnresearchcommunity

for

Search:↓

Isotretinoin may cause temporary, reversible facial hair growth in some women.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Finasteride helps hair loss patients' quality of life.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Preventing hair loss is more effective than regrowth; oral finasteride is a realistic option.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

A boy's hair, nails, and skin improved after 6 months of steroid treatment.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

Treatment with dapsone, topical corticosteroids, and antibiotics improved the man's skin conditions.

The study found that sweat glands normally suppress immune responses, but this is disrupted in certain skin diseases, possibly contributing to their development.

The document explains various skin conditions and their treatments.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

The document suggests "Occupational Skin Disease" is a useful standard text, finds "The Clinical Management of Itching" poorly organized, recommends "Atlas of Contact Dermatitis" for its illustrations, and values "Handbook of Diseases of the Hair and Scalp" for its information despite flaws.

Dermatological conditions are complex and treatments often have mixed results.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.